Machine learning reveals how metabolite profiles predict aging and health

Researchers developed metabolomic aging clocks using machine learning, uncovering links between metabolite profiles, health outcomes, and lifespan.

Adding Tucatinib to T-DM1 Shows PFS Benefit in HER2-Positive Breast Cancer

Findings from the phase III HER2CLIMB-02 trial presented at the San Antonio Breast Cancer Symposium showed that the addition of tucatinib (Tukysa) to trastuzumab emtansine

December 23, 2023

Study reveals AI’s potential and pitfalls in medical diagnosis

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and

October 29, 2024

Talkiatry & Biogen Parnter to Tackle Postpartum Depression

What You Should Know: – Talkiatry, a provider of in-network psychiatric care, is taking on the challenge of postpartum depression (PPD) with a new initiative

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.